Market Research Logo

Vision Care Devices - Medical Devices Pipeline Assessment, 2017

Vision Care Devices - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Vision Care Devices - Medical Devices Pipeline Assessment, 2017 provides an overview of Vision Care Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Vision Care Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vision Care Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vision Care Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Vision Care Devices Overview
  • Products under Development
    • Vision Care Devices - Pipeline Products by Stage of under Development
      • Table Figure 1: Vision Care Devices - Pipeline Products by Stage of under Development
      • Table Vision Care Devices - Pipeline Products by Stage of under Development
    • Vision Care Devices - Pipeline Products by Segment
      • Table Figure 2: Vision Care Devices - Pipeline Products by Segment Pipeline Products by Segment n=137
      • Table Vision Care Devices - Pipeline Products by Segment
    • Vision Care Devices - Pipeline Products by Territory
      • Table Figure 3: Vision Care Devices - Pipeline Products by Territory
      • Table Vision Care Devices - Pipeline Products by Territory
    • Vision Care Devices - Pipeline Products by Regulatory Path
      • Table Figure 4: Vision Care Devices - Pipeline Products by Regulatory Path
      • Table Vision Care Devices - Pipeline Products by Regulatory Path
    • Vision Care Devices - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Vision Care Devices - Pipeline Products by Estimated Approval Date
      • Table Vision Care Devices - Pipeline Products by Estimated Approval Date
    • Vision Care Devices - Ongoing Clinical Trials
      • Table Figure 6: Vision Care Devices - Ongoing Clinical Trials
      • Table Vision Care Devices - Ongoing Clinical Trials
  • Vision Care Devices - Pipeline Products under Development by Companies
    • Vision Care Devices Companies - Pipeline Products by Stage of Development
      • Table Vision Care Devices Companies - Pipeline Products by Stage of Development
    • Vision Care Devices - Pipeline Products by Stage of Development
      • Table Vision Care Devices - Pipeline Products by Stage of Development
  • Vision Care Devices Companies and Product Overview
    • Acuity Polymers Inc Company Overview
      • Acuity Polymers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acuity Polymers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acuity 58 - Product Status
        • Table Acuity 58 - Product Description
        • Table Acuity 85 - Product Status
        • Table Acuity 85 - Product Description
    • Adventus Technology Inc Company Overview
      • Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corneal Onlay - Product Status
        • Table Corneal Onlay - Product Description
    • Aeon Astron Corporation Company Overview
      • Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biolens - Product Status
        • Table Biolens - Product Description
        • Table Contact Lens - Product Status
        • Table Contact Lens - Product Description
    • Alcon Laboratories Inc Company Overview
      • Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Status
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Description
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - Product Status
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - Product Description
        • Table Dailies Total 1 Colors SiHy Lens - Product Status
        • Table Dailies Total 1 Colors SiHy Lens - Product Description
        • Table Dailies Total 1 Toric SiHy Lens - Product Status
        • Table Dailies Total 1 Toric SiHy Lens - Product Description
        • Table Smart Contact Lens - Diabetes - Product Status
        • Table Smart Contact Lens - Diabetes - Product Description
        • Table Weekly WG SiHy Lens - Product Status
        • Table Weekly WG SiHy Lens - Product Description
        • Table Alcon Laboratories Inc - Ongoing Clinical Trials Overview
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors
        • Table AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors
    • Allotex Inc Company Overview
      • Allotex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allotex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allotex Natural Allograft Lens - Product Status
        • Table Allotex Natural Allograft Lens - Product Description
    • Apeliotus Ophthalmics (Inactive) Company Overview
      • Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Comfort Lens - Product Status
        • Table Comfort Lens - Product Description
        • Table Contact Lens - Glaucoma - Product Status
        • Table Contact Lens - Glaucoma - Product Description
    • Auburn University Company Overview
      • Auburn University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auburn University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Contact Lenses - Product Status
        • Table Smart Contact Lenses - Product Description
    • Axcelon Biopolymers Corp. Company Overview
      • Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MC - PHEMA Based Contact Lens - Product Status
        • Table MC - PHEMA Based Contact Lens - Product Description
    • Bar-Ilan University Company Overview
      • Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bar-Ilan University Bionic Contact Lens - Product Status
        • Table Bar-Ilan University Bionic Contact Lens - Product Description
        • Table Vision Substitution Device - Product Status
        • Table Vision Substitution Device - Product Description
    • Bausch & Lomb Inc Company Overview
      • Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bausch + Lomb ULTRA Astigmatism Contact Lens - Product Status
        • Table Bausch + Lomb ULTRA Astigmatism Contact Lens - Product Description
        • Table Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Status
        • Table Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Description
        • Table Ultra Plus Powers Lens - Product Status
        • Table Ultra Plus Powers Lens - Product Description
        • Table Ultra Toric Lens - Product Status
        • Table Ultra Toric Lens - Product Description
    • Bionic Sight LLC Company Overview
      • Bionic Sight LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionic Sight LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neuro-Prosthetic Device - Product Status
        • Table Neuro-Prosthetic Device - Product Description
    • Bionic Vision Australia Company Overview
      • Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview
        • Table High-Acuity Device With 1024 Electrodes - Product Status
        • Table High-Acuity Device With 1024 Electrodes - Product Description
        • Table High-Acuity Device With 256 Electrodes - Product Status
        • Table High-Acuity Device With 256 Electrodes - Product Description
        • Table Wide-View Device With 24-channel - Product Status
        • Table Wide-View Device With 24-channel - Product Description
        • Table Wide-View Device With 44-channel - Product Status
        • Table Wide-View Device With 44-channel - Product Description
        • Table Wide-View Device With 98 Electrodes - Product Status
        • Table Wide-View Device With 98 Electrodes - Product Description
    • Bionode LLC Company Overview
      • Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionode LLC Contact Lenses - Product Status
        • Table Bionode LLC Contact Lenses - Product Description
    • Children's Hospital Boston Company Overview
      • Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contact Lens Drug Delivery Device - Product Status
        • Table Contact Lens Drug Delivery Device - Product Description
    • Consejo Superior de Investigaciones Cientificas Company Overview
      • Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Reduced Optical Instrument - Product Status
        • Table Reduced Optical Instrument - Product Description
    • CooperVision Inc Company Overview
      • CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biofinity Energys - Product Status
        • Table Biofinity Energys - Product Description
        • Table MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status
        • Table MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description
        • Table SiH Multifocal - Product Status
        • Table SiH Multifocal - Product Description
        • Table CooperVision Inc - Ongoing Clinical Trials Overview
        • Table MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses
        • Table MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial
    • Cornea Biosciences Company Overview
      • Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioengineered Cornea - Product Status
        • Table Bioengineered Cornea - Product Description
    • DeepOptics Company Overview
      • DeepOptics Pipeline Products & Ongoing Clinical Trials Overview
        • Table DeepOptics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Omnifocal Adaptive Lens - Product Status
        • Table Omnifocal Adaptive Lens - Product Description
    • eSight Corp Company Overview
      • eSight Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table eSight Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table evSpex - Product Status
        • Table evSpex - Product Description
    • Euclid Systems Corp Company Overview
      • Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-Eluting Contact Lenses - Product Status
        • Table Drug-Eluting Contact Lenses - Product Description
    • e-Vision Medical Devices, Inc. Company Overview
      • e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Electronic Contact Lens - Product Status
        • Table Electronic Contact Lens - Product Description
        • Table Electronic Focusing Eyeglasses - Product Status
        • Table Electronic Focusing Eyeglasses - Product Description
    • Eyenovations Company Overview
      • Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Dispensing Contact Lens - Product Status
        • Table Drug Dispensing Contact Lens - Product Description
    • EyeYon Medical Company Overview
      • EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSPEK - Product Status
        • Table DSPEK - Product Description
        • Table Hyper-CL - Drug Delivery - Product Status
        • Table Hyper-CL - Drug Delivery - Product Description
    • Forschungszentrum Julich GmbH Company Overview
      • Forschungszentrum Julich GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Forschungszentrum Julich GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Retinal Electrode - Product Status
        • Table Retinal Electrode - Product Description
    • iBionics Inc Company Overview
      • iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iBIONICS Diamond Eye - Product Status
        • Table iBIONICS Diamond Eye - Product Description
    • Imperial College London Company Overview
      • Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contact Lens - Product Status
        • Table Contact Lens - Product Description
    • Institute of Photonic Sciences Company Overview
      • Institute of Photonic Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Institute of Photonic Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table SMARTLENS - Product Status
        • Table SMARTLENS - Product Description
    • iSTAR Medical SA Company Overview
      • iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table STARvue - Product Status
        • Table STARvue - Product Description
    • John Hopkins University Company Overview
      • John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intra-corneal Implant - Product Status
        • Table Intra-corneal Implant - Product Description
    • Johnson & Johnson Vision Care Inc Company Overview
      • Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 1-DAY ACUVUE Multifocal Contact Lens - Product Status
        • Table 1-DAY ACUVUE Multifocal Contact Lens - Product Description
        • Table Anti-allergic Contact Lens - Product Status
        • Table Anti-allergic Contact Lens - Product Description
    • Massachusetts Eye and Ear Infirmary Company Overview
      • Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therapeutic Contact Lens - Product Status
        • Table Therapeutic Contact Lens - Product Description
    • McGill University Company Overview
      • McGill University Pipeline Products & Ongoing Clinical Trials Overview
        • Table McGill University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portable System - Amblyopia - Product Status
        • Table Portable System - Amblyopia - Product Description
    • Mercy Research and Development Company Overview
      • Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview
        • Table First Aid Lens - Product Status
        • Table First Aid Lens - Product Description
        • Table Healing Lens - Product Status
        • Table Healing Lens - Product Description
    • Meta Biomed Co Ltd Company Overview
      • Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meta Biomed Co Ltd Artificial Cornea - Product Status
        • Table Meta Biomed Co Ltd Artificial Cornea - Product Description
    • Microbiosensor Ltd Company Overview
      • Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroBioSensor - Contact Lens - Product Status
        • Table MicroBioSensor - Contact Lens - Product Description
    • Monash University Company Overview
      • Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gennaris Bionic Vision System - Product Status
        • Table Gennaris Bionic Vision System - Product Description
    • Nano Retina, Inc. Company Overview
      • Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NR600 Implant - Product Status
        • Table NR600 Implant - Product Description
    • Novartis AG Company Overview
      • Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table CLM041 - Product Status
        • Table CLM041 - Product Description
    • Ocular Dynamics, LLC Company Overview
      • Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio-inspired Contact Lens - Dry Eye Disease - Product Status
        • Table Bio-inspired Contact Lens - Dry Eye Disease - Product Description
    • Ocutec Ltd Company Overview
      • Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Third PEG Hydrogel Contact Lens - Product Status
        • Table Third PEG Hydrogel Contact Lens - Product Description
    • OPIA Technologies SAS Company Overview
      • OPIA Technologies SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table OPIA Technologies SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table OPIA Therapy Device - Ocular Surface Disorders - Product Status
        • Table OPIA Therapy Device - Ocular Surface Disorders - Product Description
        • Table OPIA Therapy Device - Retinal Disorders - Product Status
        • Table OPIA Therapy Device - Retinal Disorders - Product Description
    • Oxsight Ltd Company Overview
      • Oxsight Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxsight Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxsight Ltd Smart Glasses - Product Status
        • Table Oxsight Ltd Smart Glasses - Product Description
    • PixelOptics Inc Company Overview
      • PixelOptics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PixelOptics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Behold - Product Status
        • Table Behold - Product Description
    • Pixium Vision Company Overview
      • Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRIS II Bionic Vision System - Product Status
        • Table IRIS II Bionic Vision System - Product Description
        • Table IRIS1 - Product Status
        • Table IRIS1 - Product Description
        • Table PRIMA Bionic Vision Restoration System - Product Status
        • Table PRIMA Bionic Vision Restoration System - Product Description
        • Table Pixium Vision - Ongoing Clinical Trials Overview
        • Table IRIS II Bionic Vision System - Compensation for Blindness with the Intelligent Retinal Implant System (IRIS V2) in Patients with Retinal Dystrophy
        • Table IRIS1 - Restoring Vision with the Intelligent Retinal Implant System (IRIS V1)in Patients with Retinal Dystrophy (Title in France: Compensation of Vision with the Intelligent Retinal Implant System (IRIS V1) in Patients with Retinal Dystrophy)
    • Presbia Plc Company Overview
      • Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microlens Inserter - Product Status
        • Table Microlens Inserter - Product Description
        • Table Presbia Flexivue Microlens - Product Status
        • Table Presbia Flexivue Microlens - Product Description
        • Table Presbia Plc - Ongoing Clinical Trials Overview
        • Table Presbia Flexivue Microlens - Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens for the Improvement of Near Vision in Emmetropic Presbyopes
    • Queensland University of Technology Company Overview
      • Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spectacle Lens - Myopia - Product Status
        • Table Spectacle Lens - Myopia - Product Description
    • Refocus Group Inc Company Overview
      • Refocus Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Refocus Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VisAbility Implant System - Product Status
        • Table VisAbility Implant System - Product Description
        • Table Refocus Group Inc - Ongoing Clinical Trials Overview
        • Table VisAbility Implant System - A Prospective, Multicenter Clinical Trial of the VisAbility Implant System for Improvement of Near Visual Acuity in Presbyopic Patients
    • RetMap Inc Company Overview
      • RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CLEAr Lens - Product Status
        • Table CLEAr Lens - Product Description
    • ReVision Optics Inc Company Overview
      • ReVision Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReVision Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Raindrop Near Vision Inlay - Product Status
        • Table Raindrop Near Vision Inlay - Product Description
        • Table ReVision Optics Inc - Ongoing Clinical Trials Overview
        • Table Raindrop Near Vision Inlay - A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presybopic Patients Treated with Mitomycin C Following Femtosecond Flap Creation
        • Table Raindrop Near Vision Inlay - A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., Raindrop Near Vision Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects
    • Royal College of Surgeons in Ireland Company Overview
      • Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Royal College of Surgeons in Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table OcularColl - Product Status
        • Table OcularColl - Product Description
    • Stanford University Company Overview
      • Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biological Neural Network Based Retinal Prosthesis - Product Status
        • Table Biological Neural Network Based Retinal Prosthesis - Product Description
        • Table Polymer Network Hydrogel Contact Lens - Product Status
        • Table Polymer Network Hydrogel Contact Lens - Product Description
    • Studio Oculistico Gualdi Company Overview
      • Studio Oculistico Gualdi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Studio Oculistico Gualdi Pipeline Products & Ongoing Clinical Trials Overview
        • Table PEARL Inlay - Product Status
        • Table PEARL Inlay - Product Description
    • SynergEyes Inc Company Overview
      • SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duette Progressive With Tangible Hydra-PEG - Product Status
        • Table Duette Progressive With Tangible Hydra-PEG - Product Description
        • Table Duette With Tangible Hydra-PEG - Product Status
        • Table Duette With Tangible Hydra-PEG - Product Description
    • Tel Aviv University Company Overview
      • Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionic Eye - Product Status
        • Table Bionic Eye - Product Description
    • The University of New South Wales Company Overview
      • The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
        • Table The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stem Cell Contact Lens - Product Status
        • Table Stem Cell Contact Lens - Product Description
    • The Wilmer Eye Institute at Johns Hopkins Company Overview
      • The Wilmer Eye Institute at Johns Hopkins Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Wilmer Eye Institute at Johns Hopkins Pipeline Products & Ongoing Clinical Trials Overview
        • Table Computer Based Device - Visual Function - Product Status
        • Table Computer Based Device - Visual Function - Product Description
    • UltraVision CLPL Company Overview
      • UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview
        • Table UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview
        • Table UltraVision CLPL Contact Lenses - Product Status
        • Table UltraVision CLPL Contact Lenses - Product Description
    • University of Auckland Company Overview
      • University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vision Screening System - Product Status
        • Table Vision Screening System - Product Description
    • University of California Irvine Company Overview
      • University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Corneal Implant - Product Status
        • Table Artificial Corneal Implant - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerated Contact Lens - Product Status
        • Table Aerated Contact Lens - Product Description
        • Table Telescopic Contact Lens - Product Status
        • Table Telescopic Contact Lens - Product Description
        • Table Whole Eye Transplant - Product Status
        • Table Whole Eye Transplant - Product Description
    • University of Chicago Medical Center Company Overview
      • University of Chicago Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Chicago Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wireless Brain Implant - Product Status
        • Table Wireless Brain Implant - Product Description
    • University of Florida Company Overview
      • University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitamin E - Packed Lenses - Product Status
        • Table Vitamin E - Packed Lenses - Product Description
    • University of Illinois at Chicago Company Overview
      • University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratoprosthesis - Product Status
        • Table Keratoprosthesis - Product Description
        • Table Transcorneal Telescope - Product Status
        • Table Transcorneal Telescope - Product Description
    • University of Oxford Company Overview
      • University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionic Glass - Product Status
        • Table Bionic Glass - Product Description
        • Table Soft Tissue Retina - Product Status
        • Table Soft Tissue Retina - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corneal Replacement Prosthesis - Product Status
        • Table Corneal Replacement Prosthesis - Product Description
    • University of Tennessee Company Overview
      • University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dynamic Ocular Evaluation System - Product Status
        • Table Dynamic Ocular Evaluation System - Product Description
    • University of Tubingen Company Overview
      • University of Tubingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Tubingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table Retina Implant - Product Status
        • Table Retina Implant - Product Description
    • University of Valencia Company Overview
      • University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multifocal Contact Lens - Myopia - Product Status
        • Table Multifocal Contact Lens - Myopia - Product Description
        • Table Multifocal Contact Lens - Presbyopia - Product Status
        • Table Multifocal Contact Lens - Presbyopia - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Bionic Contact Lens - Product Status
        • Table University of Washington Bionic Contact Lens - Product Description
        • Table Solar Powered Augmented Lenses - Product Status
        • Table Solar Powered Augmented Lenses - Product Description
    • Valeant Pharmaceuticals International Inc Company Overview
      • Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotrue ONEday Toric Lenses - ASTIGMATISM - Product Status
        • Table Biotrue ONEday Toric Lenses - ASTIGMATISM - Product Description
        • Table BLC - 001: SVS - Product Status
        • Table BLC - 001: SVS - Product Description
        • Table BLC - 002: SVS - Product Status
        • Table BLC - 002: SVS - Product Description
        • Table BLC - 003: SVS/MF/fA - Product Status
        • Table BLC - 003: SVS/MF/fA - Product Description
        • Table BLC - 004: Toric - Product Status
        • Table BLC - 004: Toric - Product Description
        • Table BLC - 005: SVS/MF - Product Status
        • Table BLC - 005: SVS/MF - Product Description
        • Table BLC - 006: SVS - Product Status
        • Table BLC - 006: SVS - Product Description
        • Table BLC - 007: MF - Product Status
        • Table BLC - 007: MF - Product Description
        • Table BLC - 008: Astigmatism - Product Status
        • Table BLC - 008: Astigmatism - Product Description
        • Table BLC - 009: Astigmatism - Product Status
        • Table BLC - 009: Astigmatism - Product Description
        • Table XUV - 003: Aphakia - Product Status
        • Table XUV - 003: Aphakia - Product Description
        • Table XUV - 004: SVS - Product Status
        • Table XUV - 004: SVS - Product Description
        • Table XUV - 007: MF - Product Status
        • Table XUV - 007: MF - Product Description
        • Table XUV - 009: SVS - Product Status
        • Table XUV - 009: SVS - Product Description
        • Table XUV - 010: Astigmatism - Product Status
        • Table XUV - 010: Astigmatism - Product Description
        • Table XUV - 011: MF - Product Status
        • Table XUV - 011: MF - Product Description
        • Table XUV - 012: SVS - Product Status
        • Table XUV - 012: SVS - Product Description
        • Table XUV - 013: Astigmatism - Product Status
        • Table XUV - 013: Astigmatism - Product Description
        • Table XUV - 014: Presbyopia - Product Status
        • Table XUV - 014: Presbyopia - Product Description
        • Table XUV - 015: MF - Product Status
        • Table XUV - 015: MF - Product Description
    • Va-st Ltd Company Overview
      • Va-st Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Va-st Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Specs - Product Status
        • Table Smart Specs - Product Description
    • Visioneering Technologies Inc Company Overview
      • Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Visioneering Technologies Inc Contact Lens - Product Status
        • Table Visioneering Technologies Inc Contact Lens - Product Description
        • Table NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Status
        • Table NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Description
        • Table NaturalVue Toric 1 Day Contact Lenses - Product Status
        • Table NaturalVue Toric 1 Day Contact Lenses - Product Description
        • Table NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Status
        • Table NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Description
        • Table VTI MPC Lens - Product Status
        • Table VTI MPC Lens - Product Description
    • VISTAKON Pharmaceuticals LLC Company Overview
      • VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table K-Lens - Product Status
        • Table K-Lens - Product Description
    • Visus Technology Inc Company Overview
      • Visus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Visus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Visus Technology Inc Smart Glasses - Product Status
        • Table Visus Technology Inc Smart Glasses - Product Description
    • Weill Cornell Medical College Company Overview
      • Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prosthetic Device - Blind - Product Status
        • Table Prosthetic Device - Blind - Product Description
        • Table Prosthetic Retinal Device - Product Status
        • Table Prosthetic Retinal Device - Product Description
    • Western University Company Overview
      • Western University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Western University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Western University Artificial Cornea - Product Status
        • Table Western University Artificial Cornea - Product Description
    • Yolia Health Company Overview
      • Yolia Health Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yolia Health Pipeline Products & Ongoing Clinical Trials Overview
        • Table TVT Device - Product Status
        • Table TVT Device - Product Description
    • ZircLight Inc. Company Overview
      • ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zircs Z1 - Product Status
        • Table Zircs Z1 - Product Description
        • Table Zircs Z2 - Product Status
        • Table Zircs Z2 - Product Description
  • Vision Care Devices - Recent Developments
    • Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts
    • Sep 12, 2017: eSight 3 Launches in Australia and New Zealand
    • Sep 12, 2017: Essilor Of America Unveils Three Innovative Lens Technologies With The Ultimate Lens Package
    • Sep 11, 2017: New Data Shows DAILIES TOTAL1 Multifocal Contact Lenses Are Comfortable and Less Dry at the End of the Day
    • Sep 08, 2017: Essilor is Gold Sponsor of the 2 nd World Congress of Optometry
    • Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs
    • Sep 06, 2017: ReVision Optics Names Two Ophthalmic Experts as Medical Monitors to Oversee Raindrop Near Vision Inlay Clinical Performance
    • Sep 06, 2017: Optometrist Chooses the KAMRA Corneal Inlay for Her Solution to Reading Glasses
    • Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
    • Aug 31, 2017: The Cooper Companies Announces Third Quarter 2017 Results
    • Aug 30, 2017: Alcon revamps the packaging for its AIR OPTIX brand monthly replacement contact lenses
    • Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
    • Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand
    • Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results
    • Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results
    • Aug 09, 2017: Bausch + Lomb Receives 510(K) Clearance From FDA for the Therapeutic use of Boston XO Materials
    • Aug 09, 2017: Bausch + Lomb Receives 510(K) Clearance From FDA for the Therapeutic use of Boston XO2 Materials
    • Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results
    • Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results
    • Aug 02, 2017: Essilor wins Sustainable Business Award for its commitment to the United Nation's Sustainable Development Goals
    • Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island
    • Jul 28, 2017: Essilor International: Resilient First Half
    • Jul 28, 2017: Topcon: Notice of Changes of Executive Officers
    • Jul 27, 2017: Pixium Vision Announces H1 2017 Financial Results and Provides an Update on Its Activities
    • Jul 27, 2017: Hoya Reports First Quarter Financial Results
    • Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina
    • Jul 24, 2017: Antitrust process update for the proposed combination between Essilor and Luxottica
    • Jul 21, 2017: Sikka Software Wins API World 2017 Award for Health API, Leads the Way in Retail Healthcare Innovation
    • Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno
    • Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
    • Jul 18, 2017: Visioneering Technologies Appoints Gary Sacks as Executive Territory Manager For New York/Western Massachusetts
    • Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey
    • Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco
    • Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition
    • Jul 06, 2017: Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX Contact Lenses
    • Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego
    • Jun 29, 2017: Visioneering Technologies Announces Connie Stewart as Territory Manager, Los Angeles
    • Jun 27, 2017: Visioneering Technologies Names Mark Rapoport as New CFO
    • Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International
    • Jun 20, 2017: Visioneering Technologies Announces Dave Halverson as Territory Manager in Southern California
    • Jun 20, 2017: eSight 3 Launches in Europe
    • Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications
    • Jun 19, 2017: John Paulson Joins Valeant Board Of Directors
    • Jun 13, 2017: Pixium Vision Advances in Discussions with FDA for a Feasibility Study with Its PRIMA System for Dry-AMD
    • Jun 13, 2017: KAMRA Corneal Inlay Helps College Administrator End Her Blurry Near Vision and Dependence on Reading Glasses
    • Jun 10, 2017: Three-Year Study Indicates Pioneering Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59%
    • Jun 10, 2017: Three-year study says new contact lens therapy slows myopia progression in children by 59 percent
    • Jun 05, 2017: Acuity 58 and Acuity 85 Gas Permeable Contact Lenses Clear US FDA
    • Jun 01, 2017: The Cooper Companies Announces Second Quarter 2017 Results
    • May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
    • May 24, 2017: Pixium Vision advances in review by the French health authority for eligibility of IRIS II reimbursement under Forfait Innovation
    • May 23, 2017: Presbia Provides Update on US Staged Pivotal Clinical Trial For Flexivue Microlens
    • May 22, 2017: Bausch + Lomb Introduces renu Advanced Formula Multi-Purpose Solution
    • May 15, 2017: TearLab Corporation Reports First Quarter 2017 Financial Results
    • May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results
    • May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results
    • May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings
    • May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
    • May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance
    • May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
    • May 08, 2017: ZEISS Appoints New Fellow
    • May 07, 2017: Erevena recruits CEO for Adlens
    • May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership
    • May 03, 2017: Presbia to Participate in the 2017 ASCRS Symposium & Congress in Los Angeles, California
    • May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results
    • May 03, 2017: Pixium Vision and research partners report progress in multiple areas with IRIS and PRIMA during ARVO 2017 World Conference
    • May 02, 2017: KAMRA Corneal Inlay Utilizes Camera Technology to Sharpen and Clear Blurry Near Vision for Patients
    • May 01, 2017: Visioneering Technologies Expands US Sales Force
    • Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
    • Apr 25, 2017: Pixium Vision reports on March 31st, 2017 cash position and updates on development of its business
    • Apr 25, 2017: Essilor International: Revenue increases by 10% Q1 in line with planned 2017 growth trajectory
    • Apr 25, 2017: ZEISS Opens New Microscopy Customer Center
    • Apr 18, 2017: Varioptic launches a new 3.8mm Auto Focus S-Mount lens
    • Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO
    • Apr 04, 2017: ReVision Optics Celebrates 1,000 Raindrop Near Vision Inlay Procedures Improving Near Vision for Individuals with Presbyopia
    • Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million
    • Mar 30, 2017: Bausch + Lomb ULTRA For Astigmatism Contact Lenses Introduced
    • Mar 27, 2017: Visioneering Technologies Successfully Lists on ASX
    • Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance
    • Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS
    • Mar 15, 2017: Bausch + Lomb Introduces Biotrue ONEday For Astigmatism Contact Lenses
    • Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments
    • Mar 09, 2017: TearLab Corporation Reports Fourth Quarter and Year End 2016
    • Mar 08, 2017: The KAMRA Corneal Inlay Brings Life Back into Focus for Patients with Presbyopia, Blurring Near Vision
    • Mar 03, 2017: Visioneering Technologies Announces Launch of NaturalVue Sphere 1 Day Contact Lenses
    • Mar 03, 2017: Alcon Offers AIR OPTIX and DAILIES Choice Programs to Improve Patient Access to Affordable Contact Lens Wear
    • Mar 02, 2017: Johnson & Johnson Vision Expands Portfolio to Reach More Patients with ACUVUE OASYS 1-DAY Brand Contact Lenses for ASTIGMATISM
    • Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results
    • Mar 02, 2017: The Cooper Companies Announces First Quarter Results
    • Mar 01, 2017: Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve Symposium in San Francisco
    • Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance
    • Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting
    • Feb 24, 2017: China Grand Pharmaceutical and Healthcare Holdings: Voluntary Announcement In Related To The Products Newly Included In The 2017 National Medical Reimbursement List
    • Feb 20, 2017: Pixium Vision announces its 2016 annual results and updates on its business
    • Feb 17, 2017: Essilor International Reports 2016 Financial Results
    • Feb 16, 2017: Pixium Vision Announces First Implantation and Activation of IRIS II in Spain
    • Feb 15, 2017: Pixium Vision Appoints Didier Laurens as Chief Financial Officer
    • Feb 15, 2017: Pixium Vision appoints CFO
    • Feb 14, 2017: Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS II Bionic System in Germany
    • Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17
    • Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016
    • Jan 31, 2017: Hoya Announces Third Quarter Financial Results
    • Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
    • Jan 26, 2017: Innovative, New Tangible Hydra-PEG Contact Lens Coating Strives to Dramatically Improve the Lens Wearing Experience
    • Jan 26, 2017: Achievement of sales milestone for COPD products
    • Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback
    • Jan 24, 2017: Visioneering Technologies Announces Pam Wyman as Director, Sales Operations & Inside Sales
    • Jan 24, 2017: Center For Sight Offers Las Vegas Presbyopia Patients Newest FDAapproved Corneal Inlay Surgery for Reduced Dependence on Reading Glasses
    • Jan 18, 2017: Bausch + Lomb Introduces Zen RC Scleral Contact Lenses
    • Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL
    • Jan 11, 2017: Pixium Vision Achieves Implantation of 10 Patients in Its Clinical Trial with Its Innovative 150 Electrodes IRIS II Bionic Vision System
    • Jan 11, 2017: Paragon CRT Contact Lenses Approved by China Food & Drug Administration
    • Jan 11, 2017: Menicon appoints business development director in Europe
    • Jan 10, 2017: Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA For Presbyopia Contact Lenses
    • Jan 10, 2017: Bausch + Lomb ULTRA for Presbyopia Contact Lenses Parameters Expanded
    • Jan 10, 2017: Stephen Petranek Appointed to NexOptic Board
    • Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016
    • Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors
    • Jan 04, 2017: First Contact Lenses Specifically Designed for Digital Lifestyles Makes their CES Debut
    • Jan 03, 2017: EyeQue Personal Vision Tracker Now Available and Destined to Change How You See the World
    • Jan 03, 2017: Pixium Vision Appoints Robert J.W. ten Hoedt as Independent Member to Board of Directors
    • Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market
    • Dec 16, 2016: ZEISS Achieves Record Revenue and Earnings
    • Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area
    • Dec 12, 2016: Bausch + Lomb Specialty Vision Products Launches New 28 Lens Zenlens Dx Set
    • Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology
    • Dec 09, 2016: Carl Zeiss Meditec continues its growth trend
    • Dec 08, 2016: The Cooper Companies Announces Fourth Quarter and Full Year 2016 Results
    • Dec 07, 2016: Essilor Realigns its Organization with its Growing Businesses
    • Dec 07, 2016: VTI names executive director of manufacturing and engineering
    • Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering
    • Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda
    • Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme
    • Nov 16, 2016: New Head of the ZEISS Semiconductor Manufacturing Technology Business Group
    • Nov 14, 2016: China Grand Pharmaceutical and Healthcare Holdings: Change Of Directors
    • Nov 10, 2016: Alcon introduces new AIR OPTIX plus HydraGlyde monthly replacement contact lenses at the American Academy of Optometry annual meeting
    • Nov 10, 2016: NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results
    • Nov 09, 2016: University of Melbourne and National Vision Research Institute of Australia win $1 M grant to develop diamond bionic eye prototype
    • Nov 09, 2016: New Study Shows Groundbreaking Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59% Over Two Years
    • Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear
    • Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
    • Nov 07, 2016: Pixium Vision announces the first successful implantation and activation of IRIS II, 150 electrode bionic vision system, in the UK
    • Nov 07, 2016: TearLab Reports Third Quarter and September Year-To-Date 2016 Financial Results
    • Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results
    • Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016
    • Oct 31, 2016: NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements
    • Oct 28, 2016: Hoya Reports Second Quarter Results
    • Oct 27, 2016: VTI Introduces the NaturalVue Multifocal QuickStart Calculator
    • Oct 26, 2016: ZEISS Invests Further 60 Million Euros in the Expansion of the Semiconductor Manufacturing Technology Factory
    • Oct 26, 2016: Edmund Optics and Varioptic Announce the Availability of the Variable Focus Arctic Liquid Lens in the EO Catalog
    • Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
    • Oct 21, 2016: Essilor: Nine-Month Consolidated Revenue up 7.8% at Constant Exchange Rates
    • Oct 17, 2016: Wearable Artificial Vision Device Shows Promise in Helping People Who Are Legally Blind "Read"
    • Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
    • Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago
    • Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
    • Oct 03, 2016: Santen: Personnel Changes of Corporate Officer
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report